Merck (NYSE: MRK) reported its third quarter 2024 earnings results today.
Sales grew 4% year-over-year to $16.7 billion. Excluding FX, sales growth was 7%.
GAAP net income decreased 33% to $3.15 billion, or $1.24 per share, compared to last year. Adjusted EPS fell 26% to $1.57.
For the full year of 2024, the company expects sales of $63.6-64.1 billion and adjusted EPS of $7.72-7.77.
Prior performance
Listen to the conference calls as they happen. Don't miss a beat! With AlphaStreet Intelligence, you can listen to live calls and interviews as they happen, so you never have to worry about missing out on important information.
Most Popular
Key highlights from Nio’s (NIO) Q3 2024 earnings results
NIO Inc. (NYSE: NIO) reported its third quarter 2024 earnings results today. Total revenues were $2.66 billion, down 2.1% from the same period a year ago. Net loss attributable
Key takeaways from Walmart’s (WMT) Q3 2025 report
Over the years, Walmart Inc. (NYSE: WMT) has followed a successful business model focused on offering customers a unique shopping experience and the best prices. While the retail giant continues
What to look for when Macy’s (M) reports its Q3 2024 earnings results
Shares of Macy’s, Inc. (NYSE: M) remained red on Tuesday. The stock has dropped 14% over the past three months. The retailer is scheduled to report its third quarter 2024
